Publications by authors named "Bruce Diaz"

Claim this Profile
L
LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models.
Darlene Barnard, H Bruce Diaz, Teresa Burke, Gregory Donoho, Richard Beckmann

Invest New Drugs· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms.
Constance King, H Bruce Diaz, Samuel McNeely, Darlene Barnard, Jack Dempsey

Mol Cancer Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer.
Emiliano Calvo, Victor J Chen, Mark Marshall, Ute Ohnmacht, Scott M Hynes, H Bruce Diaz

Invest New Drugs· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase.
Hui Yang, Teresa Burke, Jack Dempsey, Bruce Diaz, Elizabeth Collins

FEBS Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.
Jill K Slack-Davis, Scott T Eblen, Maja Zecevic, Scott A Boerner, Adel Tarcsafalvi, H Bruce Diaz

J Cell Biol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein.
Kevin C Corbit, Nicholas Trakul, Eva M Eves, Bruce Diaz, Mark Marshall

J Biol Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis